Literature DB >> 10700440

Toward antiapoptosis as a new treatment modality.

A Haunstetter1, S Izumo.   

Abstract

Mesh：

Year:  2000        PMID： 10700440     DOI： 10.1161/01.res.86.4.371

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  7 in total

Review 1.  Nitric oxide, cell death, and heart failure.

Authors:  Jun-ichi Oyama; Stefan Frantz; Charles Blais; Ralph A Kelly; Todd Bourcier
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  In vivo gene delivery of XIAP protects against myocardial apoptosis and infarction following ischemia/reperfusion in conscious rabbits.

Authors:  Song-Jung Kim; Alex Kuklov; George J Crystal
Journal:  Life Sci       Date:  2011-01-25       Impact factor: 5.037

Review 3.  Necroptotic cell death in failing heart: relevance and proposed mechanisms.

Authors:  Adriana Adameova; Eva Goncalvesova; Adrian Szobi; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

4.  Activated protein C protects myocardium via activation of anti-apoptotic pathways of survival in ischemia-reperfused rat heart.

Authors:  Jia-Wang Ding; Xiao-Hong Tong; Jun Yang; Zhao-Qi Liu; Yan Zhang; Jian Yang; Song Li; Li Li
Journal:  J Korean Med Sci       Date:  2010-10-26       Impact factor: 2.153

5.  FAK regulates cardiomyocyte survival following ischemia/reperfusion.

Authors:  Zeenat S Hakim; Laura A DiMichele; Mauricio Rojas; Dane Meredith; Christopher P Mack; Joan M Taylor
Journal:  J Mol Cell Cardiol       Date:  2008-11-05       Impact factor: 5.000

6.  Leonurine protects cardiac function following acute myocardial infarction through anti‑apoptosis by the PI3K/AKT/GSK3β signaling pathway.

Authors:  Lin Xu; Xuejun Jiang; Fang Wei; Hongling Zhu
Journal:  Mol Med Rep       Date:  2018-05-29       Impact factor: 2.952

7.  Cardioprotective Effect of Nec-1 in Rats Subjected to MI/R: Downregulation of Autophagy-Like Cell Death.

Authors:  Liang Wang; Xuebai Lv; Jue Tian; Xiaoliang Wang; Ye Wu; Hui Rong Liu
Journal:  Cardiovasc Ther       Date:  2021-07-12       Impact factor: 3.023
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.